Entrada Therapeutics Inc (TRDA) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 0.78%0.91 | 0.90 | 0.88 | 1.30 | 1.61 |
7.12%42.59 | 45.86 | 43.18 | 43.51 | 48.67 | |
| Research and Development | 8.48%32.37 | 35.37 | 33.05 | 33.96 | 38.36 |
| Operating Income/Loss | 7.28%-41.69 | -44.96 | -42.30 | -42.21 | -47.05 |
| Income Tax Expense/Benefit | 22.86%0.03 | 0.04 | 0.04 | 0.09 | 0.65 |
7.06%-39.74 | -42.76 | -39.72 | -39.16 | -44.13 | |
| Attributable To Parent | 7.06%-39.74 | -42.76 | -39.72 | -39.16 | -44.13 |
| Basic Average Shares | 0.36%42.37 | 42.22 | 41.84 | 0.08 | 41.46 |
| Diluted Average Shares | 0.36%42.37 | 42.22 | 41.84 | 0.08 | 41.46 |
| Basic Earnings Per Share | 6.93%-0.94 | -1.01 | -0.95 | -0.94 | -1.06 |
| Diluted Earnings Per Share | 6.93%-0.94 | -1.01 | -0.95 | -0.94 | -1.06 |